33 employees
Galixir is an artificial intelligence technology to promote the research and development of new drugs.
2019
$10M
from 3 investors over 3 rounds
Galixir raised undisclosed on December 29, 2020
Investors: Morningside Venture Capital 晨兴资本
Galixir raised $10M on August 17, 2020
Investors: DCM Sweden AB and Morningside Venture Capital 晨兴资本